TNFSF10 and bronchopulmonary dysplasia: The clinical together with the experimental data on a persistent beneficial effect during the lung injury and a recovery period argue towards categorization of TRAIL distinct from TNF-α where excess activation was associated with more severe lung injury and BPD [24, 25].